NIH unit awards $36M grant to Beth Israel for AIDS vaccine research

07/25/2011 | American City Business Journals

The NIH's National Institute of Allergy and Infectious Diseases has awarded a $36 million grant to Beth Israel Deaconess Medical Center to spearhead a consortium that aims to study AIDS vaccines in nonhuman primates. The grant will be distributed over five years. "The goal of the consortium is to elucidate the earliest immunologic and pathologic events at mucosal surfaces following virus infection, and to determine the ability of multiple leading vaccine candidates to block or to attenuate these events," said Dr. Dan Barouch, chief of vaccine research at Beth Israel.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY